Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
72M
-
Shares change
-
+4.22M
-
Total reported value, excl. options
-
$342M
-
Value change
-
+$20.3M
-
Put/Call ratio
-
0.89
-
Number of buys
-
61
-
Number of sells
-
-19
-
Price
-
$4.76
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q2 2020
103 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q2 2020.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72M shares
of 170M outstanding shares and own 42.23% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (21.6M shares), ARK Investment Management LLC (12.5M shares), Sumitomo Mitsui Trust Holdings, Inc. (7.4M shares), Nikko Asset Management Americas, Inc. (7.4M shares), FMR LLC (5.74M shares), BlackRock Inc. (4.53M shares), VANGUARD GROUP INC (2.26M shares), RENAISSANCE TECHNOLOGIES LLC (1.39M shares), FEDERATED HERMES, INC. (1.03M shares), and JPMORGAN CHASE & CO (901K shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.